BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32540780)

  • 21. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous thromboembolism: A meta-analysis.
    Zhang H; Xie H; Wang X; Zhu Z; Duan F
    Medicine (Baltimore); 2023 Sep; 102(36):e35015. PubMed ID: 37682131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.
    Campello E; Spiezia L; Simion C; Tormene D; Camporese G; Dalla Valle F; Poretto A; Bulato C; Gavasso S; Radu CM; Simioni P
    J Am Heart Assoc; 2020 Dec; 9(23):e018917. PubMed ID: 33222589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of venous thromboembolism in cancer patients: a systematic review and meta-analysis on the efficacy and safety of different direct oral anticoagulants (DOACs).
    Song X; Liu Z; Zeng R; Shao J; Liu B; Zheng Y; Liu C; Ye W
    Ann Transl Med; 2021 Jan; 9(2):162. PubMed ID: 33569464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
    PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Bird A; Mitchell SA; Li S; Horblyuk R; Batson S
    PLoS One; 2016; 11(8):e0160064. PubMed ID: 27487187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of anticoagulant treatment in cancer patients.
    Wilts IT; Bleker SM; Van Es N; Büller HR; Di Nisio M; Kamphuisen PW
    Expert Opin Drug Saf; 2015 Aug; 14(8):1227-36. PubMed ID: 26059964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review and meta-analysis of the incidence of post-thrombotic syndrome, recurrent thromboembolism, and bleeding after upper extremity vein thrombosis.
    Espitia O; Raimbeau A; Planquette B; Katsahian S; Sanchez O; Espinasse B; Bénichou A; Murris J
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101688. PubMed ID: 37717788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV
    Ann Intern Med; 2019 Aug; 171(3):181-189. PubMed ID: 31307056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analyses.
    Cohen AT; Berger SE; Milenković D; Hill NR; Lister S
    Pharmacol Res; 2019 May; 143():166-177. PubMed ID: 30905806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study.
    Brunetti ND; Gesuete E; De Gennaro L; Correale M; Caldarola P; Gaglione A; Di Biase M
    Int J Cardiol; 2017 Mar; 230():214-221. PubMed ID: 28062137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes.
    Larsen TB; Nielsen PB; Skjøth F; Rasmussen LH; Lip GY
    PLoS One; 2014; 9(12):e114445. PubMed ID: 25479007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis.
    Katel A; Aryal M; Neupane A; Gosain R; Pathak R; Bhandari Y; Kouides P
    Cureus; 2021 Apr; 13(4):e14572. PubMed ID: 34026385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism.
    Kang N; Sobieraj DM
    Thromb Res; 2014 Jun; 133(6):1145-51. PubMed ID: 24713109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.
    Al Yami MS; Silva MA; Donovan JL; Kanaan AO
    J Thromb Thrombolysis; 2018 Jan; 45(1):36-47. PubMed ID: 29043538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis.
    Valeriani E; Porreca E; Weitz JI; Schulman S; Candeloro M; Di Nisio M
    J Thromb Haemost; 2020 Jul; 18(7):1661-1671. PubMed ID: 32202042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis.
    Chen H; Tao R; Zhao H; Jiang J; Yang J
    Medicine (Baltimore); 2020 Jan; 99(5):e19000. PubMed ID: 32000440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.